How to Help Your Patients Find Crestor in Stock: A Provider's Guide

Your Patients Can't Find Crestor — Here's How to Help

When patients call your office to say their pharmacy is out of Rosuvastatin, it creates a cascade of work: return calls, medication changes, new prescriptions, and follow-up. In 2026, with localized supply disruptions and a recent generic recall, these calls are becoming more frequent.

This guide gives your clinical team a practical playbook for helping patients maintain statin therapy when Rosuvastatin is temporarily unavailable.

Current Availability: What You Need to Know

As of 2026, here's the landscape for Rosuvastatin:

• No formal FDA shortage — but real-world availability is inconsistent
• January 2026 recall — approximately 30,000 bottles of generic Rosuvastatin recalled for dissolution issues; some strengths more affected than others
• 5 mg and 10 mg are generally easier to find than 20 mg and 40 mg
• Independent pharmacies often have different supply channels and may have stock when chains don't
• Mail-order pharmacies tend to have more consistent inventory

Why Patients Can't Find It

Understanding the root causes helps you counsel patients and set expectations:

1. The recall reduced available supply: Removing tens of thousands of bottles from circulation creates a gap that takes time to fill
2. Just-in-time pharmacy inventory: Chain pharmacies don't maintain large buffer stocks — when a delivery is late or demand spikes, they run out quickly
3. High prescription volume: Rosuvastatin is a top-10 most-prescribed medication. Small supply disruptions get amplified by sheer volume
4. Strength-specific issues: Some strengths may be affected while others aren't. Patients may not know to ask about alternatives
5. Patient timing: Many patients fill at the same time (beginning of the month, right when they run out), creating demand spikes

What Providers Can Do: 5 Practical Steps

Step 1: Direct Patients to Medfinder

Before your staff spends time calling pharmacies, direct patients to Medfinder. The platform helps patients search for Rosuvastatin availability by zip code, saving both your team and your patients valuable time.

Consider adding Medfinder to your standard patient instructions for any medication that may have availability issues. A simple handout or after-visit summary note can empower patients to self-serve.

Step 2: Pre-Authorize Alternative Statins

When prescribing Rosuvastatin, consider adding a note to the chart (and, where state law allows, to the prescription) identifying an acceptable alternative statin and equivalent dose:

• Rosuvastatin 5 mg → Atorvastatin 10 mg
• Rosuvastatin 10 mg → Atorvastatin 20 mg
• Rosuvastatin 20 mg → Atorvastatin 40 mg
• Rosuvastatin 40 mg → Atorvastatin 80 mg

This allows a faster switch if the patient calls back unable to fill, and gives on-call providers the information they need to act without a full chart review.

Step 3: Recommend Strength Flexibility

If a specific strength is unavailable, patients may not think to ask about alternatives. Proactively discuss options like:

• Taking two tablets of a lower strength (e.g., two 10 mg instead of one 20 mg)
• Switching to a nearby available strength with dose adjustment
• Trying the Ezallor Sprinkle capsule formulation, which may have different availability

Step 4: Prescribe 90-Day Supplies When Appropriate

Longer prescription durations reduce the number of times a patient needs to find stock. Benefits include:

• Fewer refill-related availability issues
• Lower per-pill cost for many patients
• Better adherence (fewer pharmacy trips = fewer chances to miss a refill)
• Mail-order 90-day supplies are particularly reliable

Step 5: Build a Supply Disruption Protocol

Develop a standard workflow for your practice to handle medication availability calls efficiently:

1. Front desk directs patient to Medfinder as first step
2. If patient still can't find medication, clinical staff reviews chart for pre-identified alternative
3. Provider approves switch and sends new prescription (ideally same day)
4. Schedule follow-up labs in 6-8 weeks after any statin switch
5. Document the reason for the change in the chart

Having this protocol in place reduces the burden on providers and ensures patients don't experience dangerous gaps in therapy.

Alternatives to Consider

When Rosuvastatin is unavailable, the most common switches are:

Atorvastatin (Lipitor)

The closest match in potency. High-intensity at 40-80 mg. Widely available and affordable ($3-$15/month generic). Key consideration: more CYP3A4 drug interactions than Rosuvastatin.

Pitavastatin (Livalo)

Good option for patients with diabetes risk concerns. Moderate-to-high intensity. Generic available but pricier ($15-$50/month). Fewer drug interactions.

Pravastatin (Pravachol)

Best option for patients on complex drug regimens who need minimal interaction risk. Moderate intensity only. Very affordable ($4-$15/month generic).

Add-On Therapy: Ezetimibe

If switching to a lower-intensity statin, adding Ezetimibe (Zetia) can provide an additional 15-20% LDL reduction. Generic Ezetimibe is $10-$20/month. Consider the fixed-dose combination Roszet (Rosuvastatin + Ezetimibe) if available.

For a patient-facing resource on alternatives, see Alternatives to Crestor.

Workflow Tips for Your Practice

• Add Medfinder to your EHR quick links — making it easy for staff to reference during patient calls
• Create a statin equivalency reference card — keep it accessible in the prescribing workflow
• Flag high-risk patients — post-ACS, FH, and patients on Rosuvastatin for specific interaction reasons should be prioritized for proactive outreach if supply issues worsen
• Use prescription renewal visits as an opportunity to discuss backup plans with patients before they encounter a stock-out
• Document Rosuvastatin selection rationale — if you chose it specifically for its interaction profile, renal dosing, or other clinical reason, note this clearly so colleagues can make informed decisions

Final Thoughts

Rosuvastatin supply disruptions in 2026 are manageable with preparation. By directing patients to tools like Medfinder, pre-identifying alternative statins, and building a simple supply disruption protocol, your practice can minimize the impact on both patient care and clinical workflow.

The goal is straightforward: keep patients on appropriate statin therapy with minimal gaps, regardless of which specific statin they end up taking.

Related resources: Crestor shortage: what providers need to know | Helping patients save money on Crestor | Crestor drug interactions